Arcus Biosciences (RCUS) Amortizatization of Intangibles (2017 - 2026)

Arcus Biosciences' Amortizatization of Intangibles history runs 10 years deep, the most recent figure standing at $3.0 million for Q1 2026.

• On a quarterly basis, Amortizatization of Intangibles fell 25.0% year-over-year to $3.0 million in Q1 2026; TTM through Mar 2026 was $12.0 million, a 47.83% decrease from a year earlier, with the FY2025 full-year figure at $13.0 million, down 48.0% from the prior year.
• Amortizatization of Intangibles was little changed at $3.0 million in Q1 2026 per RCUS's latest filing, from $3.0 million in the prior quarter.
• Across five years, Amortizatization of Intangibles topped out at $7.0 million in Q2 2024 and bottomed at -$2.0 million in Q1 2022.
• The 5-year median for Amortizatization of Intangibles is $4.0 million (2023), against an average of $4.0 million.
• Across the five-year window, Amortizatization of Intangibles plunged 295.26% in 2022 and soared 300.0% in 2023, its largest moves.
• Year by year, Amortizatization of Intangibles stood at $2.0 million in 2022, then soared by 200.0% to $6.0 million in 2023, then changed by 0.0% to $6.0 million in 2024, then sank by 50.0% to $3.0 million in 2025, then changed by 0.0% to $3.0 million in 2026.
• Per Business Quant, the three latest RCUS Amortizatization of Intangibles figures stand at $3.0 million (Q1 2026), $3.0 million (Q4 2025), and $3.0 million (Q3 2025).